BBD controls n = 86 | BBD cases n = 86 | P^{a} | P^{b} | P^{c} | |
---|---|---|---|---|---|

Any CLS-B, n (%) | 16 (18.6%) | 21 (24.4%) | 0.07 | 0.09 | 0.11 |

>5 CLS-B, n (%) | 4 (4.7%) | 9 (10.5%) | 0.007 | 0.01 | 0.02 |

Number of CLS-B (among CLS-B–positive samples) | |||||

Median (range) | 3 (1–55) | 5 (1–37) | 0.81 | 0.80 | 0.84 |

CLS-B density^{d} (among CLS-B–positive samples) | |||||

Median (range) | 2.7 (0.7–19.7) | 3.3 (0.7–27.0) | 0.74 | 0.33 | 0.42 |

MSS, n (%) | 0.54 | 0.73 | 0.93 | ||

1 | 25 (29.1%) | 30 (34.9%) | |||

2 | 37 (43.0%) | 33 (38.4%) | |||

3 | 24 (27.9%) | 23 (26.7%) | |||

Mean (SD) | 1.99 (0.76) | 1.92 (0.79) |

↵

^{a}*P*value from conditional logistic regression, adjusted for adipose area (cm^{2}) for measures not standardized to area.↵

^{b}*P*value from conditional logistic regression adjusting for adipose area (cm^{2}) as above and also histologic impression.↵

^{c}*P*value from conditional logistic regression adjusting for adipose area (cm^{2}) as above and also histologic impression and BMI.↵

^{d}Lesions/cm^{2}adipose tissue